Initial Evaluation of the ClearLLab10C System in the Immunophenotyping of Leukemia

Mike Keeney from Lawson Health Research Institute, Ontario, will present "Initial evaluation of the ClearLLab 10C System in the Immunophenotyping of Leukemia and Non Hodgkin Lymphoma".
The presentation will introduce the new ClearLLab 10 Color System and the ClearLLab Control Cells, the first application-specific IVD control cells for leukemia and lymphoma* immunophenotyping as part of a validated system. He will then demonstrate the applicability of the system in evaluation of leukemia at Non-Hodgkin Lymphoma and will evaluate the results of the clinical accuracy study.
Objectives:
- Understand the process in routine cocktail selection and preparation
- Describe the key concepts in the ClearLLab 10 color system design
- Demonstrate using case studies the applicability of ClearLLab reagents in the evaluation of leukemia and NHL
- Evaluate the results of the clinical accuracy study
Speaker:
Mike Keeney ART, FCSMLS(D)
Coordinator, Investigational Hematology
Associate Scientist, Lawson Health Research Institute, London Health Sciences Centre
Original Broadcast: May 15th, 2019